ACLARIS THERAPEUTICS INC (ACRS)

Company Profile

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. The company is headquartered in Wayne, Pennsylvania and currently employs 105 full-time employees. The company went IPO on 2015-10-07. The firm is engaged in developing a pipeline of drug candidates to address the needs of patients with immuno-inflammatory diseases. The firm has a multi-stage portfolio of drug candidates powered by a robust research and development (R&D) engine exploring protein kinase regulation. The firm operates through two segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. The contract research segment includes provision of laboratory services. The firm is also engaged in identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize its novel drug candidates.

Company Info

ACLARIS THERAPEUTICS INC

701 Lee Road, Suite 103

Wayne PENNSYLVANIA 19087

P: 14843247933

CEO: Neal Walker

Employees: 105

Website: https://www.aclaristx.com/